BioPharma Dive - Latest News

Amgen obesity drug on hold; Regeneron sets first dividend

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic alternatives.”  

Feb 9, 2025 - 21:44
 0
Amgen obesity drug on hold; Regeneron sets first dividend

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic alternatives.”

 

Read More

Tags:

Previous Article

Novo outlines new late-stage study of obesity drug CagriSema

Next Article

AI tool helps find life-saving medicine for rare disease

Related Posts

Advamed CEO warns FDA cuts put patients, industry at risk

Advamed CEO warns FDA cuts put patients, industry at risk

Feb 20, 2025  0

Lilly CEO wields manufacturing plans to push pharma-friendly policies

Lilly CEO wields manufacturing plans to push pharma-fri...

Feb 26, 2025  0

Lilly expands US manufacturing build-out with $50B target

Lilly expands US manufacturing build-out with $50B target

Feb 26, 2025  0